Status: Current Private

Xcell Biosciences

Commercial-stage life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing.

Ellie Diagnostics

Disruptive animal health provider delivering innovative diagnostic solutions to veterinarians and pet owners across the United States.

Antios Therapeutics

Clinical-stage biotechnology company developing innovative therapies to treat and cure chronic hepatitis B virus (HBV).

Ribon Therapeutics

Clinical-stage biotechnology company pursuing the development of novel small molecules that target cancer through its dependency on stress support pathways.

Arch Oncology

Clinical-stage immuno-oncology company that aims to discover and develop potential best-in-class antibody therapies for the treatment of patients with cancer.

Amber Ophthalmics

Clinical-stage ophthalmic company focused on novel therapeutics to address unmet medical needs, providing for the restoration, preservation, and improvement of patient vision and quality of life.

Sebela Pharmaceuticals

Commercial-stage specialty pharmaceutical company focused on gastrointestinal, dermatological, and women’s health products.

Saol Therapeutics

Clinical-stage therapeutics company focused on the central nervous system (CNS), orphan diseases, and conditions with high unmet medical need.